LOW PULSE-WAVE AMPLITUDE DURING REACTIVE LEG HYPEREMIA - AN INDEPENDENT, EARLY MARKER FOR ISCHEMIC-HEART-DISEASE AND DEATH - RESULTS FROM THE 21-YEAR FOLLOW-UP OF THE PROSPECTIVE COHORT STUDY, MEN-BORN-IN-1914, MALMO, SWEDEN

Citation
B. Hedblad et al., LOW PULSE-WAVE AMPLITUDE DURING REACTIVE LEG HYPEREMIA - AN INDEPENDENT, EARLY MARKER FOR ISCHEMIC-HEART-DISEASE AND DEATH - RESULTS FROM THE 21-YEAR FOLLOW-UP OF THE PROSPECTIVE COHORT STUDY, MEN-BORN-IN-1914, MALMO, SWEDEN, Journal of internal medicine, 236(2), 1994, pp. 161-168
Citations number
24
Categorie Soggetti
Medicine, General & Internal
ISSN journal
09546820
Volume
236
Issue
2
Year of publication
1994
Pages
161 - 168
Database
ISI
SICI code
0954-6820(1994)236:2<161:LPADRL>2.0.ZU;2-N
Abstract
Objective. To study the incidence of myocardial infarction, all-cause mortality and mortality from ischaemic heart disease in relation to ar terial leg blood flow determined by venous occlusion plethysmography o f the calf. Design. A prospective cohort study 'Men born in 1914'. Set ting, Malmo, a city in southern Sweden with 256 000 inhabitants, and a single referral hospital. Subjects. Six-hundred and thirty-six 55-yea r-old men, randomly selected from the general population.None of them had signs or symptoms of leg artery disease. Main outcome measures. Al l-cause mortality, morbidity and mortality from ischaemic heart diseas e during 21 years of follow-up following the initial examination in 19 68. Results. A low pulse-wave amplitude (i.e. < 5 mm) during reactive hyperaemia was, independently of other known arteriosclerotic risk fac tors, associated with a higher cardiac event rate of 37.1% (relative r isk: 2.2; 95% CI: 1.3-3.6) and a higher all-cause mortality rate of 62 .9% (relative risk: 1.7; 95% CI: 1.2-2.4) during 21 years of follow-up . No other plethysmographically recorded variable was associated with an increased mortality and cardiac event rate. Conclusions. The plethy smographically recorded pulse-wave amplitude during reactive hyperaemi a can be used as an early independent marker to identify individuals a t risk of developing ischaemic heart disease and death at an early age .